Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.35 HKD
−1.02 B HKD
245.29 M HKD
209.47 M
About ASCENTAGE PHARMA GROUP INTL
Sector
Industry
CEO
Da Jan Yang
Website
Headquarters
Suzhou
Founded
2009
FIGI
BBG00PGD9WQ0
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company, which engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. It operates through United States and Mainland China geographical segments. The company was founded by Dajun Yang and Ming Guo in May 2009 and is headquartered in Suzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6855 is 42.95 HKD — it has decreased by −2.72% in the past 24 hours. Watch ASCENTAGE PHARMA GROUP INTL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ASCENTAGE PHARMA GROUP INTL stocks are traded under the ticker 6855.
6855 stock has risen by 4.37% compared to the previous week, the month change is a 4.50% rise, over the last year ASCENTAGE PHARMA GROUP INTL has showed a 65.51% increase.
We've gathered analysts' opinions on ASCENTAGE PHARMA GROUP INTL future price: according to them, 6855 price has a max estimate of 67.55 HKD and a min estimate of 46.61 HKD. Watch 6855 chart and read a more detailed ASCENTAGE PHARMA GROUP INTL stock forecast: see what analysts think of ASCENTAGE PHARMA GROUP INTL and suggest that you do with its stocks.
6855 reached its all-time high on Jul 15, 2021 with the price of 58.20 HKD, and its all-time low was 11.15 HKD and was reached on May 10, 2022. View more price dynamics on 6855 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6855 stock is 4.57% volatile and has beta coefficient of 0.94. Track ASCENTAGE PHARMA GROUP INTL stock price on the chart and check out the list of the most volatile stocks — is ASCENTAGE PHARMA GROUP INTL there?
Today ASCENTAGE PHARMA GROUP INTL has the market capitalization of 13.46 B, it has decreased by −3.94% over the last week.
Yes, you can track ASCENTAGE PHARMA GROUP INTL financials in yearly and quarterly reports right on TradingView.
ASCENTAGE PHARMA GROUP INTL is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
6855 net income for the last half-year is 176.63 M HKD, while the previous report showed −565.32 M HKD of net income which accounts for 131.24% change. Track more ASCENTAGE PHARMA GROUP INTL financial stats to get the full picture.
No, 6855 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 583.00 employees. See our rating of the largest employees — is ASCENTAGE PHARMA GROUP INTL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASCENTAGE PHARMA GROUP INTL EBITDA is −276.20 M HKD, and current EBITDA margin is −367.00%. See more stats in ASCENTAGE PHARMA GROUP INTL financial statements.
Like other stocks, 6855 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASCENTAGE PHARMA GROUP INTL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASCENTAGE PHARMA GROUP INTL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASCENTAGE PHARMA GROUP INTL stock shows the buy signal. See more of ASCENTAGE PHARMA GROUP INTL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.